The novel HLA‐B*51:381 allele, identified in a Chinese individual through Sanger dideoxy nucleotide sequencing
HLA · 2023
DOI: 10.1111/tan.15130 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2023. Verfasst von Hang Lei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: HLA-B Antigens. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
HLA‐B*51:381 differs from HLA‐B*51:01:01:01 by one nucleotide in exon 5.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Blood Transfusion Department, Ruijin Hospital, Medical School of Shanghai Jiao Tong University, Shanghai, China.
- Shanghai Institute of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China.
ORCID-Profile: Hang Lei
Zitieren
APA
Lei, H., Jiang, C. H., Du, K. M., Zheng, Z. Z., & Cai, X. H. (2023). The novel HLA‐B*51:381 allele, identified in a Chinese individual through Sanger dideoxy nucleotide sequencing. HLA. https://doi.org/10.1111/tan.15130
Vancouver
Lei H, Jiang CH, Du KM, Zheng ZZ, Cai XH. The novel HLA‐B*51:381 allele, identified in a Chinese individual through Sanger dideoxy nucleotide sequencing. HLA. 2023. doi:10.1111/tan.15130
BibTeX
@article{Lei2023,
author = {Lei, Hang and Jiang, Chuan-He and Du, Ke-Ming and Zheng, Zhong-Zheng and Cai, Xiao-Hong},
title = {The novel HLA‐B*51:381 allele, identified in a Chinese individual through Sanger dideoxy nucleotide sequencing},
journal = {HLA},
year = {2023},
doi = {10.1111/tan.15130}
}
EUVIMED